EJCTS Click here for details of sales representative
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Eur J Cardiothorac Surg 2008;34:350-353. doi:10.1016/j.ejcts.2008.05.004
Copyright © 2008, European Association for Cardio-thoracic Surgery. Published by Elsevier. All rights reserved.

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Vermeijden, W. J.
Right arrow Articles by de Vries, A. J.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Vermeijden, W. J.
Right arrow Articles by de Vries, A. J.
Related Collections
Right arrow Cardiac - other
Right arrow Extracorporeal circulation

Do repeated runs of a cell saver device increase the pro-inflammatory properties of washed blood?

Wytze J. Vermeijden*, Ans Hagenaars, Willem van Oeveren, Adrianus J. de Vries

Department of Anesthesiology, University Medical Centre Groningen, University of Groningen, The Netherlands

Received 19 December 2007; received in revised form 5 May 2008; accepted 6 May 2008.

* Corresponding author. Address: Department of Anesthesiology, Thorax Centre Twente, Medisch Spectrum Twente, Enschede, Haaksbergerstraat 55, 7513 ER Enschede, The Netherlands. Tel.: +31 53 487 20 00. (Email: verm0030{at}planet.nl).

Objective: Intra-operative cell salvage is increasingly used, especially in longer cases with continuing blood loss. However it is unknown if the quality of processed blood is affected when larger quantities of blood are processed. We hypothesized that the quality of the washed blood decreases after multiple runs. Methods: Intra-operative cell salvage was performed in 42 consecutive patients undergoing cardiac surgery. When 1250 ml of blood was collected in the blood collection reservoir, this was processed and returned to the patient. In 21 patients more than 2500 ml of blood was collected during the whole procedure, thus allowing at least two subsequent runs with the auto-transfusion device. Blood samples were drawn from the blood collection reservoir of the cell saver device before, and from the processed blood after each run. Results: After the first run interleukin-6 concentrations were reduced with 85% (from 21 ± 35 µg/l to 3.1 ± 4.4 µg/l), whereas after the second run 72% was removed (63 ± 69 µg/l to 17.6 ± 25.3 µg/l). Leukocyte counts almost doubled after both processing runs (from 2.6 ± 1.5 x 109/l to 5 ± 3.6 x 109/l) and from 3.9 ± 2.2 x 109/l to 7.7 ± 5.9 x 109/l), hemoglobin concentration (14.8 ± 1.6 mmol/l vs 15.0 ± 1.1 mmol/l), free hemoglobin (2.3 ± 1.6 g/l vs 2.1 ± 1.4 g/l) and platelet counts (18 ± 9 x 109/l vs 28 ± 23 x 109/l) were not different between the two runs. Conclusions: Our results suggest, based on interleukin-6 and free hemoglobin washout that the quality of the processed blood remains constant with multiple runs of the cell saver device.

Key Words: Cell saver • Interleukins • Cardiac surgery • Blood quality







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2008 European Association for Cardio-Thoracic Surgery. Published by Elsevier. All rights reserved.